Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Marinus Pharmaceuticals Inc (MRNS): Are Hedge Funds Right About This Stock?

With a general bullishness amongst the heavyweights, specific money managers were breaking ground themselves. Iguana Healthcare Management, managed by Stuart Weisbrod, initiated the most valuable position in Marinus Pharmaceuticals Inc (NASDAQ:MRNS). Iguana Healthcare Management had $0.6 million invested in the company at the end of the quarter. William Leland Edwards’s Palo Alto Investors also made a $0.5 million investment in the stock during the quarter. The following funds were also among the new MRNS investors: Peter Muller’s PDT Partners and Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital.

Let’s check out hedge fund activity in other stocks similar to Marinus Pharmaceuticals Inc (NASDAQ:MRNS). We will take a look at Pure Cycle Corporation (NASDAQ:PCYO), Energy Focus Inc (PINK:EFOI), TRACON Pharmaceuticals Inc (NASDAQ:TCON), and Xenon Pharmaceuticals Inc (NASDAQ:XENE). This group of stocks’ market values are similar to MRNS’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
PCYO 8 51382 1
EFOI 6 2216 5
TCON 5 12671 0
XENE 8 21808 -1

As you can see these stocks had an average of 6.75 hedge funds with bullish positions and the average amount invested in these stocks was $22 million. That figure was $5 million in MRNS’s case. Pure Cycle Corporation (NASDAQ:PCYO) is the most popular stock in this table. On the other hand TRACON Pharmaceuticals Inc (NASDAQ:TCON) is the least popular one with only 5 bullish hedge fund positions. Marinus Pharmaceuticals Inc (NASDAQ:MRNS) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard PCYO might be a better candidate to consider a long position.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.